Early Stage Partners led the Series A investment in the life sciences company Imalux, which is pioneering medical imaging devices based on optical coherence tomography, and has continued to support the company through multiple investment rounds, including leading the Series C and Series D rounds. The Company's Niris(R) Imaging System, based on Optical Coherence Tomography (OCT), has been cleared by the FDA. The Niris is used to view tissue microstructure, and provides clinicians with in situ information not available from any other imaging technology.
Recent Imalux News
Imalux Hires Former Philips Executive Jim Fulton as President and COOImalux Wins Third Frontier Grant to Accelerate Commercialization
Find Out More About ESP
Jonathan Murray manages Early Stage Partners' investment in and serves on the board of Imalux.